Summary
Machine-generated summaryHUS (Helsinki University Hospital) Diagnostic Center is conducting a market consultation to prepare a procurement of a urine-based bladder cancer methylation test for its ISO 15189 accredited Laboratory of Genetics in Finland. The buyer seeks supplier input on two test formats: a standard test (A) and a rapid test (B). Thousands of samples per year are expected, but no estimated value is stated. Responses, which may cover one or both formats, must be emailed to kilpailutus.diagnostiikka@hus.fi by 17 March 2026 with the subject line HUS 440-2025 Bladder Methylation Test.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile1 open tender right now
- Finland - Medical equipments, pharmaceuticals and personal care products - Large Cancer Panel Test 8 days left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Triolab Oy | 1 | €700,000 | Dec 2025 |
| Bio-Rad Finland Oy; VWR International Oy; BioNordika Oy | 1 | €690,500 | Feb 2026 |
| Reagena Oy | 1 | €535,450 | Feb 2026 |
| Labema Oy; EntroGen | 1 | €60,000 | Oct 2025 |
Based on 4 awards with a linked company profile over the last 5 years.
Similar tenders
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €8,978,645
- Buyer track record on Aperlena
- 25 notices tracked · 6 awarded
- €3,029,470 in awarded contracts
Never miss a tender like this
Get an email for new tenders matching: Medical equipment & pharmaceuticals · Finland. Free.
Set up my alert